StateViewer

by Mayo Clinic  · Based in United States → — AI-powered insights for early and precise dementia diagnosis.
Neurology Nuclear Medicine Radiology

Contact for pricing

Overview

StateViewer is an artificial intelligence (AI) tool developed by Mayo Clinic’s Neurology Artificial Intelligence Program (NAIP) designed to assist clinicians in diagnosing various neurodegenerative diseases, particularly dementias.

What it does: StateViewer analyzes fluorodeoxyglucose positron emission tomography (FDG-PET) brain scans. It compares an individual patient’s scan to a large database of confirmed dementia cases to identify patterns of brain activity and glucose metabolism associated with specific types of dementia. The tool can identify patterns linked to nine types of dementia, including Alzheimer’s disease, Lewy body dementia, and frontotemporal dementia.

Who it is for: This tool is intended for neurologists and other clinicians involved in the diagnosis and management of patients with suspected neurodegenerative conditions. It may be particularly beneficial in care settings that may lack immediate access to specialized neurology expertise.

How it fits a clinical or practice workflow: StateViewer integrates into the diagnostic workflow by providing an AI-powered analysis of FDG-PET scans. The tool generates color-coded brain maps that visually highlight key areas of brain activity, offering a visual explanation of the AI’s findings to clinicians. This output can be reviewed during multidisciplinary case conferences to support diagnostic decision-making.

Notable capabilities: StateViewer has demonstrated the ability to identify dementia types with an 88% accuracy rate in studies. It has also been shown to potentially enhance the speed of scan interpretation and diagnostic accuracy for clinicians. The tool’s design aims to provide clear, interpretable insights to support clinicians in distinguishing between various complex neurodegenerative diseases.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Analyzes FDG-PET brain scans
  • Identifies patterns linked to 9 types of dementia (e.g., Alzheimer's, Lewy body, frontotemporal dementia, posterior cortical atrophy, corticobasal syndrome, progressive supranuclear palsy)
  • Compares patient scans to a large reference dataset of confirmed dementia cases (over 3,600 scans)
  • Produces color-coded brain activity maps highlighting disease patterns
  • Enhances diagnostic accuracy (88% accuracy in identifying dementia types)
  • Increases speed of interpretation (nearly twice as fast as standard workflows)
  • Improves diagnostic accuracy for clinicians (up to three times greater accuracy than standard practices)
  • Aids in distinguishing between dementias with similar symptoms
  • Provides visual explanations of AI findings for clinicians
  • Designed to support, not replace, clinical decision-making

Use Cases

  • Early and precise diagnosis of various dementia types
  • Supporting clinical decision-making in neurology
  • Expanding access to specialist-level insights in clinics lacking neurology expertise
  • Guiding treatment decisions for patients with dementia
  • Differentiating between multiple overlapping or coexisting dementia conditions
  • Assisting in the diagnosis of reversible causes of dementia

What Physicians Need to Know

Evidence Base
StateViewer was trained and validated on over 3,600 FDG-PET brain scans from individuals with confirmed dementia diagnoses and those with no cognitive decline. The underlying machine learning model uses a modified k-nearest neighbor (K-NN) algorithm.
Clinical Validation Studies
StateViewer has been successfully piloted by Mayo neurologists as a research tool. Studies have shown a significant enhancement in the accuracy of clinicians' interpretations of brain images, surpassing what is achievable with current tools alone. In a radiologic reader study, clinicians using StateViewer had 3.3 ± 1.1 times greater odds of making a correct diagnosis than those using standard-of-care practices. The tool achieved a sensitivity of 0.89 ± 0.03 and an area under the receiver operating characteristic (ROC) curve of 0.93 ± 0.02 in distinguishing neurodegenerative phenotypes. It correctly identified dementia types 88% of the time in a study.
Differential Diagnosis Support
StateViewer can identify 9 different types of dementia, including Alzheimer's disease, Lewy body dementia, frontotemporal dementia (including subtypes like behavioral variant, logopenic variant primary progressive aphasia, nonfluent primary progressive aphasia, semantic dementia), posterior cortical atrophy, corticobasal syndrome, and progressive supranuclear palsy. It is particularly helpful in distinguishing between dementia types with similar symptoms, such as Lewy body dementia and posterior cortical atrophy. The tool generates color-coded brain activity maps to highlight regions matching specific disease patterns.
Clinical Workflow Integration
StateViewer has been successfully piloted by Mayo neurologists as a research tool and is used for patients in Mayo's Alzheimer's Disease Treatment Clinic with a PET scan available. The outputs of StateViewer may be reviewed at weekly multidisciplinary case conferences to inform precision medicine-based recommendations. It has been shown to enable nearly twice the speed of interpretation. The platform is designed to integrate AI with clinician expertise to improve diagnostic accuracy and patient outcomes. It is deployed in practice on an investigational basis across the enterprise and the Mayo health system. StateViewer is a clinical decision support application that leverages AI and ML technology to improve diagnostic accuracy and efficiency, reducing reading time by 50%.
Physician Tip

StateViewer is a powerful AI tool designed to augment, not replace, clinical decision-making in diagnosing dementia. Leverage its ability to rapidly analyze FDG-PET scans and provide color-coded brain maps to enhance diagnostic accuracy and differentiate between complex neurodegenerative phenotypes, especially in cases with overlapping symptoms. The tool can significantly reduce interpretation time and offer expert-level insights, potentially expanding access to specialized dementia diagnostics.

StateViewer is a Mayo-created platform that takes an individual patient's PET scan and applies AI to find similar cases of brain disease in Mayo's distributed data network. It operates within the Mayo Clinic Cloud, an innovative technology platform developed in collaboration with Google Cloud, allowing real-time access and analysis of clinical imaging data. The platform, called NetD, connects cloud-based data, multimodal models, and clinical workflows to enable scalable and adaptive neurology. StateViewer is considered a Class 2 software as a medical device for analytics.

Details

Category Clinical Decision Support & Reference, Neurology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentCloud-computing approach (Mayo Clinic Cloud, in collaboration with Google Cloud)
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Unknown
Integrations
EHR Not specified
Specialties Neurology, Nuclear Medicine, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate StateViewer

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for StateViewer.

View all on YouTube

Frequently Asked Questions

StateViewer is a clinical decision support (CDS) tool designed to provide real-time, evidence-based guidance at the point of care. It integrates with your existing EHR to offer patient-specific recommendations, alerts for potential drug interactions, and summaries of relevant clinical guidelines, aiming to enhance diagnostic accuracy and treatment efficacy.
StateViewer incorporates the latest clinical guidelines from recognized authorities and updates its knowledge base regularly. It provides clear citations for its recommendations, helping you demonstrate adherence to best practices and regulatory standards. The system also tracks user interactions for audit purposes, supporting compliance efforts.
Yes, there are several other CDS tools available, each with varying features. StateViewer differentiates itself through its intuitive interface, comprehensive integration capabilities, and a focus on actionable, patient-specific insights. While other tools may offer similar functionalities, StateViewer aims for a balance of robust evidence and user-friendly design to minimize alert fatigue and maximize utility.
StateViewer typically offers tiered pricing models based on the size of the practice or institution and the scope of features required. There are often subscription options for individual physicians, small clinics, and larger hospital systems, with varying levels of support and customization. Specific pricing details can be obtained by contacting our sales team for a personalized quote.
While StateViewer is a powerful tool, it's important to remember it's a support system, not a replacement for clinical judgment. Potential limitations include the need for accurate and complete EHR data for optimal recommendations, and the possibility of alert fatigue if not configured appropriately. It's designed to augment your decision-making, not automate it entirely, and its effectiveness relies on proper integration and user engagement.
StateViewer employs a dedicated team of medical experts and data scientists who continuously monitor new research, clinical trials, and guideline updates from authoritative sources. Its knowledge base is regularly updated and validated to ensure that the recommendations provided are based on the most current and evidence-based medical information available.
Yes, StateViewer offers a degree of customization to align with specific specialties and clinical pathways. While the core knowledge base is broad, physicians can often configure preferences, prioritize certain guidelines, and tailor alert settings to better suit their individual practice patterns and patient populations. This helps to optimize its relevance and minimize irrelevant notifications.

Related Tools

Stanford University
Stanford University
Clinical Decision Support & Reference
Stanford Online's "AI in Healthcare" program provides a comprehensive overview of artificial intelligence's applications and implications within the medical field.
RADIN Health
RADIN Health
Clinical Decision Support & Reference
RADINA is an AI-powered platform by RADIN Health designed to optimize radiology workflows, enhance diagnostic accuracy, and streamline reporting.
Med-PaLM 2
Google
Clinical Decision Support & Reference
Med-PaLM 2 is a large language model from Google, fine-tuned for healthcare to provide high-quality answers to medical questions and support clinical decision-making.
Pacmed Critical Discharge
Pacmed
Clinical Decision Support & Reference
Pacmed Critical Discharge is an AI tool that predicts the probability of death or readmission within seven days of ICU discharge, providing explainable insights for physicians.
AiZtech Labs
AiZtech Labs
Clinical Decision Support & Reference
AiZtech Labs provides enterprise-grade AI solutions for healthcare, focusing on operational efficiency, diagnostic accuracy, and patient care workflows for providers and health systems.
Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-07-01 | First Added: 2026-07-01
AI Tool Finder
AI-powered search. Results may not be comprehensive.